oxamniquine has been researched along with Kidney Failure, Chronic in 1 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Schistosomiasis is a major health problem in some areas of the world." | 1.31 | Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up. ( Baz, ME; El-Agroudy, AE; Ghoneim, MA; Mahmoud, KM; Mostafa, FE; Shokeir, AA; Sobh, MA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahmoud, KM | 1 |
| Sobh, MA | 1 |
| El-Agroudy, AE | 1 |
| Mostafa, FE | 1 |
| Baz, ME | 1 |
| Shokeir, AA | 1 |
| Ghoneim, MA | 1 |
1 other study available for oxamniquine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up.
Topics: Adult; Anthelmintics; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplanta | 2001 |